The endocrinological outcome in four patients with pituitary macroadenomas laterally invading the cavernous sinus, who were treated surgically by the transcranial transcavernous approach, was compared with that in four patients with macroadenomas that had been removed transsphenoidally. 
Transsphenoidal surgery for patients with pituitary adenomas is now a widely used surgical procedure because of its relative simplicity and the satisfactory results it provides. For example, the cure rates for lactotroph and somatotroph microadenomas reported in the literature range from 57% to 93% (1) (2) (3) (4) (5) (6) (7) (8) (9) and from 78% to 97% (10) (11) (12) , respectively. However, the corresponding rates for lactotroph and somatotroph macroadenomas treated by transsphenoidal surgery alone are reportedly as low as 14-63% (1, 2, 4-9, 13) and 42-89% (10) (11) (12) (Fig. la) . The (Fig. 3a) . The (Fig. 3b) . Daily oral intake of 2.5 mg of bromocriptine achieved a normal PRL level (3 ng/ml). (Fig. 7a) , whereas in transcranial transcavernous surgery the anterior clinoid process is removed and the cavernous sinus is opened widely, thus allowing extensive exposure and removal of the tumor (Fig. 7b) . (24) and has some dependency-related side effects (25, 26) . Several non-surgical treatments, including dopamine agonists (27) 
